Literature DB >> 2968130

Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer.

H Parmar1, G Rustin, S L Lightman, R H Phillips, I W Hanham, A V Schally.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968130      PMCID: PMC2545706          DOI: 10.1136/bmj.296.6631.1229

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma.

Authors:  C M Richman; E Podczaski; P A Weiser; A L Herbst
Journal:  Oncology       Date:  1986       Impact factor: 2.935

2.  Randomised controlled study of orchidectomy vs long-acting D-Trp-6-LHRH microcapsules in advanced prostatic carcinoma.

Authors:  H Parmar; R H Phillips; S L Lightman; L Edwards; L Allen; A V Schally
Journal:  Lancet       Date:  1985-11-30       Impact factor: 79.321

3.  How to induce ovarian cancer: and how not to.

Authors:  J S Scott
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-29

4.  Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.

Authors:  R W Shaw; H M Fraser; H Boyle
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03
  4 in total
  3 in total

1.  Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone.

Authors:  T Yano; J Pinski; S Radulovic; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

2.  Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.

Authors:  T Yano; J Pinski; G Halmos; K Szepeshazi; K Groot; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

Review 3.  Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review).

Authors:  Hongyi Li; Yu Liu; Yang Wang; Xia Zhao; Xiaorong Qi
Journal:  Oncol Rep       Date:  2021-08-26       Impact factor: 3.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.